Rheumatoid arthritis Companies
Rheumatoid arthritis is a chronic autoimmune disorder that primarily affects the joints, causing inflammation and pain.
Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
Latest Rheumatoid Arthritis Companies Update
MyMD receives FDA approval for a Phase 2 clinical trial of MYMD-1, a potential oral medication for RA, marking a significant step towards a first-in-class oral treatment option.
Bristol-Myers Squibb's TYVYTUS® (sirukumab) wins FDA approval for the treatment of active ankylosing spondylitis, expanding its reach beyond RA and offering patients another therapeutic option.
Eli Lilly's Olumiant® (baricitinib) demonstrates positive results in Phase 3 trial for axial spondyloarthritis, potentially expanding its application beyond RA and demonstrating its promising efficacy in related inflammatory conditions.
AbbVie and Genentech form a collaboration to develop and commercialize JAK inhibitors for autoimmune diseases, combining their expertise and pipeline to accelerate research and development efforts.
Pfizer enters a strategic partnership with BioXcel Therapeutics to develop novel treatments for immune-mediated diseases, including RA, leveraging BioXcel's expertise in AI-powered drug discovery.
List of Rheumatoid Arthritis Key Companies in the Market
- Pfizer Inc (U.S)
- Eli Lilly and Company (U.S)
- Bristol-Myers Squibb Company (U.S)
- Hoffmann-La Roche Ltd (Switzerland)
- Novartis AG (Switzerland)
- Bayer AG (Germany)
- Vertex Pharmaceuticals Incorporated (U.S)
- Sanofi (France)
- Cipla Ltd. (India)
- AstraZeneca (U.K)
Rheumatoid arthritis Market Highlights:
Rheumatoid arthritis Market Highlights:
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
